Eppendorf AG, a leading name in the life sciences industry, is headquartered in Hamburg, Germany (DE). Founded in 1945, the company has established itself as a pioneer in laboratory equipment and consumables, serving researchers and scientists across the globe. Eppendorf's core business areas include liquid handling, sample handling, and cell culture, with innovative products such as pipettes, centrifuges, and bioreactors that are renowned for their precision and reliability. With a strong presence in Europe, North America, and Asia, Eppendorf has achieved significant milestones, including numerous awards for product excellence and sustainability initiatives. The company is committed to advancing scientific research, making it a trusted partner in laboratories worldwide. Eppendorf's dedication to quality and innovation solidifies its position as a market leader in the life sciences sector.
How does Eppendorf's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Eppendorf's score of 28 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Eppendorf SE reported total carbon emissions of approximately 7009000 kg CO2e for Scope 1, 1805000 kg CO2e for Scope 2 (market-based), and significant Scope 3 emissions, including about 2256000 kg CO2e from business travel and approximately 246561000 kg CO2e from the use of sold products. The total market-based emissions for Scope 1 and 2 combined reached about 8814000 kg CO2e. Eppendorf's emissions data for previous years shows a slight decrease in Scope 1 emissions from about 7076000 kg CO2e in 2021 and 6838000 kg CO2e in 2020. Scope 2 emissions also decreased from approximately 2023000 kg CO2e in 2021 to 1805000 kg CO2e in 2022. However, Scope 3 emissions have remained substantial, with the use of sold products consistently contributing the largest share. Eppendorf has committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is not currently committed to a net-zero target. Their climate initiatives are aligned with industry standards, and they are actively working towards improving their sustainability practices within the pharmaceuticals, biotechnology, and life sciences sector. The emissions data is sourced directly from Eppendorf SE, with no cascading from a parent or related organization.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 7,644,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 13,202,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 86,074,000 | 00,000,000 | 00,000,000 | 000,000,000 |
Eppendorf's Scope 3 emissions, which increased by 313% last year and increased by approximately 196% since 2019, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 97% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eppendorf has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
